|
 |
|
|
|
CAS No.: 2586-96-1 Formula: C37H42N2O6
Weight: 610.73900
Synonyms: 4-[[(1r)-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl]-2-[[(1r)-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-yl]oxy]phenol;LIENSININE;Hiensinine;Liensinine4-[[(1R)-6,7-Dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[[(1R)-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phChemicalbookenol;2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]-;Phenol,4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-;4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenol;Liensinineperchlorafe
Modern research shows that liensinine has various cardiovascular activities such as lowering blood pressure, slowing down heart rate, inhibiting myocardial contractility, anti-arrhythmia, etc.; it can also reduce lipid peroxidation injury, and has a protective effect on myocardial ischemia-reperfusion injury in rats , Niensinine can reduce the production of lipid peroxide MDA, enhance the activity of serum SOD and Chemicalbook GSH-Px, thereby reducing a series of cell damage reactions caused by free radicals; it can also effectively increase the local ATP content in the ischemic area of the brain , reducing the lactic acid content, significantly improving the energy metabolism of cerebral ischemia tissue, thereby improving the neurological dysfunction of cerebral ischemia-reperfusion rats and reducing the scope of cerebral infarction.
